Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F1GFB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,224
Award facts
- Contract value 100% obligated
- $5,224.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,224.28 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company demonstrates extensive capability in fulfilling federal pharmaceutical supply requirements across multiple therapeutic domains, with its federal contract portfolio encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The DLA's reliance on AmerisourceBergen through its substantial IDC reflects the company's established competence in meeting complex federal medical supply chain demands across diverse customer bases including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F1GFB?
SPE2DR26F1GFB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1GFB worth?
The government has obligated $5,224 on SPE2DR26F1GFB.
Is contract SPE2DR26F1GFB an order under another contract?
Yes. SPE2DR26F1GFB is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GFB competed?
The extent of competition for SPE2DR26F1GFB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award